Kristin Anne Connarn

Kristin Anne Connarn

Hogan Lovells

Contact
View Bio
RSS

Latest Posts › Food and Drug Administration (FDA)

Share:

New Orange & Purple Book laws increase transparency of patent information for drugs, biologics

On January 5, 2021, President Trump signed into law H.R. 1503, the "Orange Book Transparency Act of 2020," which amends provisions governing the types of patents and exclusivity-related information for approved drugs listed...more

1/21/2021  /  Biologics , Food and Drug Administration (FDA) , Life Sciences , New Legislation , Orange Book , Patents , Pharmaceutical Patents , Purple Book , Regulatory Reform , Transparency
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide